Russia has introduced a cancer vaccine for the first time.

      According to "RBK," Russia has for the first time used a domestic cancer vaccine. The drug was administered to a patient with skin melanoma at the National Medical Research Center for Radiology.

      This is a personalized mRNA vaccine, which is created individually for each patient based on the characteristics of the tumor. The goal of the drug is to "train" the immune system to recognize and destroy cancer cells.

      The first patient is a 60-year-old resident of the Kursk region. He was diagnosed with melanoma back in 2021. After surgery, the disease began to progress, so doctors decided to apply the new therapy. The man is currently continuing treatment.

      The vaccine is administered in stages: first, several injections with increasing doses, followed by maintenance shots every three weeks. The entire course may include up to ten administrations.

      The Ministry of Health notes that this is not a "miracle cure," but an additional tool for doctors. However, specialists call the technology groundbreaking, as it offers a fundamentally new approach to the treatment of oncological diseases.

      It should be noted that similar vaccines are just beginning to be used, and it is too early to talk about mass use — scientists still need to assess their effectiveness and safety.